Liver fibrosis increases the risk of subclinical atherosclerosis in patients with MASLD: a cross-sectional and longitudinal study

This study investigated the associations between both the progression and regression of liver fibrosis and subclinical atherosclerosis in patients withmetabolic dysfunction-associated steatotic liver disease (…

​This study investigated the associations between both the progression and regression of liver fibrosis and subclinical atherosclerosis in patients withmetabolic dysfunction-associated steatotic liver disease (… Read More